Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Disodium etidronate therapy for dystrophic cutaneous calcification.

Disodium etidronate therapy for dystrophic cutaneous calcification. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Disodium etidronate therapy for dystrophic cutaneous calcification. Abstract Text:

    A patient with extensive disabling dystrophic cutaneous calcification and possible scleroderma was treated with orally administered doses of a diphosphonate known as disodium etidronate. This course of therapy seemed to arrest and partially reverse the progression of the calcifying process. Some deep deposits were then seen to dissipate and be partially reabsorbed, while some small superficial depcific deposits were halted in most areas while the patient was under therapy. Clinically, pain was reduced, recurrent abscess formation ceased, and joint mobility was improved.

    Disodium etidronate therapy for dystrophic cutaneous calcification. Publishing Authors By Initials

    For similar skin and connective tissue diseases: skin diseases research abstracts see: skin and connective tissue diseases: skin diseases research

    PUBMED ID PMID:

    MEDLINE DATE:

    Disodium etidronate therapy for dystrophic cutaneous calcification. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Archives of dermatology

    VOLUME: 111

    Page Numbers: 357-61

    Journal Abbreviation: Arch Dermatol

    ISSN: 0003-987X

    DAY: 17

    MONTH: Mar

    YEAR: 1975

    Disodium etidronate therapy for dystrophic cutaneous calcification. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372433

    Disodium etidronate therapy for dystrophic cutaneous calcification. Keywords Mesh Terms:

    KEYWORDS: Skin Diseases

    MESH TERMS: radiography

    Chemical & Substance for Abstract: Disodium etidronate therapy for dystrophic cutaneous calcification. Information

    Substance Name: Etidronic Acid

    Registry Number: 2809-21-4

    Grant and Affiliation Information for Disodium etidronate therapy for dystrophic cutaneous calcification.

    AFFILIATION:

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Arch Dermatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Disodium etidronate therapy for dystrophic cutaneous calcification Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News